Giuseppe Del - 01 Aug 2022 Form 3 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Role
Chief Medical Officer
Signature
/s/ Giuseppe Del Priore
Issuer symbol
BCTX
Transactions as of
01 Aug 2022
Transactions value $
$0
Form type
3
Filing time
01 Aug 2022, 16:10:43 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCTX Stock Option 01 Aug 2022 Common Shares 150,000 $7.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option vests quarterly for 2 years from the date of grant.